+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Viral Vector"

Cell and Gene Therapy Manufacturing Services Market - Product Thumbnail Image

Cell and Gene Therapy Manufacturing Services Market

  • Report
  • July 2023
  • 138 Pages
  • Global
From
2021 Biotechnology Research Review - Product Thumbnail Image

2021 Biotechnology Research Review

  • Report
  • February 2022
  • 312 Pages
  • Global
From
Global Markets for Vaccine Technologies - Product Thumbnail Image

Global Markets for Vaccine Technologies

  • Report
  • January 2024
  • 213 Pages
  • Global
From
Nasal Vaccines: Global Markets and Pipeline Analysis - Product Thumbnail Image

Nasal Vaccines: Global Markets and Pipeline Analysis

  • Report
  • December 2022
  • 78 Pages
  • Global
From
From
From
From
Advances in Gene Editing Technologies in Healthcare - Product Thumbnail Image

Advances in Gene Editing Technologies in Healthcare

  • Report
  • January 2023
  • 103 Pages
  • Global
From
From
Technology Growth Opportunities for Exosome-Mediated Drug Delivery - Product Thumbnail Image

Technology Growth Opportunities for Exosome-Mediated Drug Delivery

  • Report
  • September 2022
  • 62 Pages
  • Global
From
Technological Advances in RNA Stabilization & Delivery - Product Thumbnail Image

Technological Advances in RNA Stabilization & Delivery

  • Report
  • November 2021
  • 73 Pages
  • Global
From
Loading Indicator

The Viral Vector market is a subset of the biotechnology industry that focuses on the development and production of viral vectors for gene therapy. Viral vectors are modified viruses that are used to deliver genetic material into cells, allowing for the expression of a desired gene. This technology has been used to treat a variety of diseases, including cancer, genetic disorders, and infectious diseases. Viral vectors are produced through a variety of methods, including recombinant DNA technology, synthetic biology, and cell-based systems. The production of viral vectors requires specialized equipment and expertise, making it a highly specialized field. The Viral Vector market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Novartis, Merck, Pfizer, AstraZeneca, and Sanofi. Additionally, there are a number of smaller companies that specialize in the production of viral vectors, such as Viralgen, Oxford BioMedica, and Vigene Biosciences. Show Less Read more